“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...

Weight loss from glucagon-like peptide 1 agonists clearly alleviates knee osteoarthritis pain, but other recently published data give pause regarding possible long-term adverse effects.

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...